Enter Symbol:

Stock Detail

GLAXOSMITHKLINE PLC

Drug Manufacturers Major

GSK @ Yahoo Finance | GSK Option @ Yahoo Finance

Last Day's Data

Current Price High Value Change Percent Change Dividend Previous Close
$43.88 $44.49 $-0.76 -1.70% 2.12 $44.64
Opening Price Low Volume Market Cap Average Volume P/E
$44.15 $43.88 1.77M 110.36B 3.25M 21.32

Pivot Table

R2 R1 Pivot S1 S2
44.69 44.28 44.08 43.67 43.47

stock chart

Stock Profile

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical and consumer health-related products worldwide. The company operates in two segments, Pharmaceuticals and Consumer Healthcare. The Pharmaceutical segment offers prescription pharmaceuticals and vaccines. Its primary pharmaceutical products include medicines in nine therapeutic areas, including central nervous system, respiratory, anti-virals, anti-bacterials, vaccines, oncology and emesis, metabolic, cardiovascular, and urogenital. The Consumer Healthcare segment provides various over-the-counter medicines, oral care, and nutritional healthcare products. Its oral care products include toothpastes and mouthwashes, toothbrushes, and denture care products. Its nutritional healthcare products include glucose energy and sports drinks, a blackcurrant juice-based drink with vitamin C, and a range of milk-based malted food and chocolate drinks. GlaxoSmithKline has a strategic alliance with Theravance, Inc. to develop and commercialise medicines across a various therapeutic areas; Cytokinetics, Inc. to discover, develop, and commercialize small molecule drugs targeting kinesin spindle protein and certain other cytoskeletal proteins involved in cell proliferation for applications in the treatment of cancer and other diseases; and a partnership with Aeras Global TB Vaccine Foundation to develop GSK Biologicals' tuberculosis candidate vaccine Mtb72F/AS02A. The company was founded in 1935 and is headquartered in London.